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The effects of beta-adrenergic blockade, thrombolysis and 
their combination on infarct size and left ventricular func- 
tion were investigated in a canine model of thrombotic 
occlusion of the left anterior descending coronary artery. 
Metoprolol was administered intravenously (0.5 mglkg) 
over 10 min, starting 15 min after occlusion. Recombinant 
human tissue-type plasminogen activator (rt-PA) was given 
intravenously 1 h after occlusion for clot lysis. Anatomic 
infarct size was measured as a percent of perfusion area 
and ventricular mass. Left ventricular function was as- 
sessed by ejection fraction and the centerline method. 
Groups 1, 3, 5 and 7 were evaluated after 24 h and 
received, respectively, metoprolol plus rt-PA, rt-PA, meto- 
pro101 and no treatment; groups 2,4, 6 and 8 were studied 
after 1 week and treated, respectively, as groups 1,3,5 and 
7. Metoprolol did not influence infarct size and global or 
regional ventricular function after 24 h and 1 week. Throm- 
The residual amount of viable myocardium after acute 
myocardial infarction is important for the short- and long- 
term prognosis (1,2). Reduction of infarct size has been 
attempted with beta-adrenergic blocking agents (3-5), but 
results remaln conflicting. Timely reperfusion of an occluded 
coronary artery has in recent years been shown to reduce 
infarct size (69). 
A recent report from our laboratory (10) showed that the 
combination of early beta-adrenergic blockade followed by 
coronary reperfusion resulted in an earlier recovery of 
regional left ventricular function, which was present after 
24 h but did not persist after 1 week. Infarct size tended to be 
somewhat smaller in animals receiving this combination 
therapy. In the present study, the number of animals, 
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bolysis reduced infarct size from 69.5 2 3.4% (24 h) and 
76.6 + 1.8% (1 week) in the control group to, respectively, 
44.1 + 11.6% and 39.5 f 10.5% (p > 0.05), did not 
influence left ventricular function after 24 h and was 
accompanied after 1 week by a definite recovery of global 
and regional left ventricular function when compared with 
findings in control dogs. Metoprolol plus r&PA further 
reduced infarct size (percent perfusion area) to 20.4 f. 
3.7% and 19.9 f 8.1% after 24 h and 1 week, respectively 
(P = NS versus &PA). After 24 h, a significant early 
recovery of global and regional left ventricular function was 
present; this better recovery persisted after 1 week. 
It is concluded that early administration of metoprolol 
plus r&PA enhances the effects of thrombolysis on infarct 
size and left ventricular function after 24 h and 1 week. 
(J Am Coil Cardiol1989;14:1816-23) 
included in our previous study (lo), was extended to better 
equalize the area at risk in all groups and to include a 
subgroup treated with beta-blockers only. The more sensi- 
tive centerline method was used for the analysis of regional 
left ventricular function. 
In this way, we hoped to demonstrate a persisting effect 
of the combination of beta-blockade and reperfusion on left 
ventricular function after 1 week and to delineate the effect 
of beta-blockade alone on ventricular function after 24 h and 
1 week in this particular model of acute myocardial infarc- 
tion . 
Methods 
Animal preparation and experimental protocol. Mongrel 
dogs (n = 101) of both sexes, weighing between 13 and 27 kg, 
were anesthetized with 15 mg/kg sodium pentobarbital, 
intubated and ventilated with a Bird respirator. Catheters 
were inserted into the descending aorta, pulmonary artery 
and left ventricle through, respectively, a femoral artery and 
vein and the left carotid artery. 
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The copper coil technique was used in all dogs to provoke 
an occlusive thrombus just distal to the first main diagonal 
branch of the left anterior descending coronary artery (11). 
The following eight groups were studied: group 1 (11 dogs) 
and group 2 (8 dogs) treated with beta-blockade followed by 
reperfusion and investigated, respectively, after 24 h and 1 
week; group 3 (12 dogs) and group 4 (15 dogs) treated with 
reperfusion alone and examined, respectively, after 24 h and 
1 week; group 5 (11 dogs) and group 6 (13 dogs) treated only 
with beta-blockade and studied, respectively, after 24 h and 
1 week; group 7 (14 dogs) and group 8 (17 dogs) did not 
receive treatment and were evaluated, respectively, after 
24 h and 1 week. 
Reperfusion. In groups 1, 2, 5 and 6, an intravenous 
infusion of metoprolol was started 15 min after coronary 
occlusion at a rate of 1 mg/min up to a total dose of 0.5 
mg/kg. An intravenous infusion of two chain or single chain 
recombinant tissue-type plasminogen activator @-PA) (Ge- 
nentech Inc.) was administered in groups 1, 2, 3 and 4 1 h 
after occlusion at a rate of 10 pg/kg per min for 30 min. When 
intravenous thrombolysis was unsuccessful, intracoronary 
rt-PA was given. At the end of the experiments, all catheters 
were removed. In the reperfusion groups, the copper coil 
was also removed, but this was not the case in the other 
groups. All incisions were sutured, and after extubation 
aprindine (50 mg) and piperacillin (2 g) were slowly admin- 
istered intravenously. 
After 24 h or after 1 week, the surviving dogs were 
reexamined as just described. At the end of the experiments, 
the animals were killed by intravenous administration of 
saturated potassium chloride and the heart removed for 
determination of infarct size. 
Determination of infarct size. Infarct size was measured 
as previously described (12). The ostia of the left and right 
coronary arteries and the left anterior descending coronary 
artery just distal to the site of the occlusion were cannulated 
and simultaneously perfused at a pressure of 120 mm Hg 
during 10 min, with, respectively, Evans blue or triphe- 
nyltetrazolium chloride. After fixing the heart with 2% 
glutaraldehyde, the left ventricle was cut in 10 mm thick 
slices perpendicularly to the apex-base axis and the differ- 
ently stained area measured by planimetry. The perfusion 
area was expressed as a percent of left ventricular area, and 
infarct size as a percent of perfusion area and left ventricular 
area. 
Analysis of left ventricular function. Left ventricular an- 
giograms were performed by injection of Renografin-76 
(diatrizoate meglumine and diatrizoate sodium) (1 ml/kg) into 
the left ventricle during diastole, at a rate of 12 ml/s by 
means of an R wave-triggered injection pump as previously 
described (10,13). Left ventricular cavity borders were man- 
ually outlined at end-diastole and end-systole. Global ejec- 
tion fraction was calculated by a modified area-length 
method (14), and regional wall motion was analyzed by the 
centerline method (13,15). In brief, a centerline was con- 
structed midway between the end-diastolic and end-systolic 
contours and 100 chords were drawn perpendicularly to the 
centerline, connecting both contours. The chord length or 
systolic motion was normalized by dividing its length by the 
end-diastolic perimeter. The normalized motion (Mi) is a 
dimensionless unit; for standardization, mean (Ni) and stan- 
dard deviation (SDi) of Mi at each chord (i) were calculated 
from 54 normal baseline left ventriculograms. The standard- 
ized motion of a chord (Zi) was expressed as Zi = Mi - 
Ni/SDi. 
To dejine the territory of the left anterior descending 
coronary artery, the mean of the standardized motion of a 
chord in 54 dogs during occlusion was calculated for each 
chord. The set of contiguous chords, where this mean value 
was c-1 standard deviation, was considered as the territory 
of the left anterior descending coronary artery. It extended 
from chord 12 to 66, numbered clockwise from the aortic 
valve. The mean value for these 55 chords was calculated on 
each ventriculogram and used for further analysis. The mean 
standardized motion of the 50% most abnormally contracting 
chords in the left anterior descending coronary artery terri- 
tory was also calculated (mZi 50%). The number of contig- 
uous chords in the left anterior descending coronary artery 
territory with standardized motion c-2 standard deviations 
was determined. Finally, the negative area was computed by 
summing all negative chord motion values in the left anterior 
descending coronary artery territory. 
All experiments conformed to the “Position of the Amer- 
ican Heart Association on Research Animal Use” adapted 
November 11, 1984 by the American Heart Association. 
Statistical analysis. Results are expressed as mean + 
standard error of the mean. Differences within and between 
groups were evaluated using a two-way analysis of variance. 
When a significant difference was found, Tukey’s multiple 
comparison method was used to determine the specific 
difference between the mean values (16). 
Results 
General findings. Thirty-one animals died before comple- 
tion of the study. Of the 70 survivors, 17 had to be excluded 
because of failure to stain the myocardium (3 dogs), ventric- 
ular arrythmias during angiography (6 dogs) or inadequate 
perfusion area (occlusion of diagonal branch instead of left 
anterior descending coronary artery in 4 dogs or late occlu- 
sion of a large diagonal branch through thrombus growth 
also in 4 dogs. We attempted to have the same number of 
animals in each subgroup with a nearly identical mean 
perfusion area. Therefore, five more dogs were excluded. 
The mean occlusion time in groups 1, 2, 3 and 4 was not 
significantly different. 
The mean plasma level of metoprolol in 24 dogs (groups 
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Figure 1. Infarct size expressed as a percent of the perfusion area 
(I/P). C = control group; M = group receiving only metoprolol 
intravenously; M t T = group receiving combined therapy with 
metoprolol and it-PA; OCCL = occlusion; PERM OCCL = perma- 
nent occlusion; REP = reperfusion; T = group undergoing throm- 
bolysis with intravenous recombinant tissue-type plasminogen acti- 
vator @t-PA). Values are expressed as mean t standard error of the 
mean *p < 0.05; **p < 0.01. 
1, 2, 5 and 6) 45 min after the end of infusion was 166.3 ? 
78.5 rig/ml and was not different among the four groups,. 
Infarct size (Fig. 1, Table 1). There were no significant 
differences in mean percent left ventricular perfusion area 
Table 1. Perfusion Area and Infarct Size (%) in the Eight 
Treatment Groups 
No. PILV VP ULV 
Evaluation After 24 h 
Group 1 6 28.9 + 3.2 
Group 3 6 31.3 r 3.5 
Group 5 6 35.5 + 2.0 
Group 7 6 33.7 ? 2.6 
Evaluation After 1 Week 
Group 2 6 27.7 * 2.5 19.9 + 6.7 2 Group 4 6 31.2 2 0.7 r35.9 * 8.1 1 10.5 11.4 2 1.9 1 3.5 
* 
Group6 6 26.9 2 3.3 43.6 f 10.3 +  8 34 ? 2 6 L 76 .8 J :::; 5 :::_i 
*p < 0.05; tp < 0.01. Groups I and 2 treated with combined reperfusion 
and beta-blockade; groups 3 and 4 treated with reperfusion alone; groups 5 
and 6 treated with beta-blockade alone; groups 7 and 8 no treatment (control). 
Values are expressed as mean + SEM. IlLV = infarct size expressed as 
percent of the left ventricular area; I/P = infarct size expressed as percent of 
the perfusion area; No. = number of experimental animals; P/LV = perfusion 
area of the left coronary artery expressed as percent of the left ventricular 
area. 
among the eight treatment groups, but it varied from 26.9 to 
35.5%. After 24 h, infarct size as a percent of perfusion area 
and left ventricular area was nearly identical in the control 
animals (group 7) and those treated with metoprolol (group 
5). Infarct size as a percent of perfusion area and left 
ventricular area was lowest in group 1; the values in group 3 
were intermediate between groups 1, 5 and 7. Only the 
differences among groups 1 and 5 and groups 1 and 7 were 
significant. The percent perfusion area was nearly identical 
in groups 5 and 7 and reasonably similar in groups 1 and 3; it 
was, however, lower in groups 1 and 3 than in 5 and 7. 
After 1 week, infarct size as a percent of perfusion area 
and ventricular area was lowest in group 2 and highest in 
group 8; the values in groups 4 and 6 were similar and 
intermediate between groups 2 and 8. The differences in 
these values for infarct size between groups 2 and 8 and 
groups 4 and 8 were significant. For infarct size as a percent 
of ventricular area, the difference between groups 2 and 8 
was also significant; perfusion area as a percent of ventric- 
ular area was lowest in group 6 and highest in group 8. 
In summary, infarct size was smaller in the combined 
reperfusion and beta-blockade treatment group at 24 h 
(group 1) and at 1 week (group 2) compared with that in the 
groups treated with reperfusion alone (groups 3 and 4) or 
beta-blockade alone (groups 5 and 6). 
Global ejection fraction (Fig. 2). Under control conditions 
and during acute occlusion, left ventricular ejection fraction 
was not different among the eight treatment groups; left 
ventricular ejection fraction decreased significantly during 
acute occlusion in each subgroup. 
After 24 h, left ventricular ejection fraction was lower 
than immediately after occlusion in groups 3, 5 and 7, but 
this difference was only significant in group 7. In group 1, left 
ventricular ejection fraction after 24 h was slightly higher 
than after occlusion and it was higher than in groups 3,5 and 
7. 
In groups 2, 4, and 8, left ventricular ejection fraction 
after 1 week was higher than immediately after occlusion and 
this was significant in groups 2 and 4; in group 6 it remained 
unchanged. Left ventricular ejection fraction at 1 week 
increased almost to control values in groups 2 and 4, but 
remained significantly below these values in groups 6 and 8. 
In summary, left ventricular ejection was higher in the 
combined treatment group (Group 1) at 24 hours compared 
with that in the group treated with reperfusion alone (Group 
3) or beta-blockade alone (Group 5). At 1 week, ejection 
fraction had risen to almost control levels in the combined 
treatment (Group 2) and in the group treated with reperfu- 
sion alone (Group 4) but not in the other groups (Groups 6 
and 8). 
Regional wall motion (Fig. 3 to 5). Under baseline condi- 
tions and during acute occlusion, no differences in mean 
standardized wall motion in 55 chords and of the 50% most 
abnormal chords, the number of chords with standardized 
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Figure 2. Global ejection fraction (EF). Open bars 
are the values under baseline conditions, batched 
bars are values during acute coronary occlusion 
and closed bars are values at follow-up study. 
BB = beta-adrenergic blocking agent (metoprolol); 
OCCL = occlusion of left anterior descending coro- 
nary artery without therapy; II-PA = recombinant 
tissue-type plasminogen activator; 1 to 8 indicate the 
experimental groups; other abbreviations as in Fig- 
ure 1. 
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motion c-2 standard deviations and the total negative area 
were found among the eight groups. In each subgroup, the 
decrease in regional wall movement from control to acute 
occlusion was significant. 
In groups 3, 5 and 7 after 24 h, the changes in mean 
standardized chord motion either persisted or became 
slightly (but not significantly) more pronounced. However, 
after 24 h, in group 1 it was higher (but not significantly) than 
immediately after occlusion; in group 1 it was higher after 
24 h than in groups 3, 5 and 7 and this was significant for 
groups 3 and 7. 
One week after coronary occlusion in groups 2, 4, 6 and 
8, mean standardized chord motion was higher than imme- 
diately after occlusion; this difference was significant in 
groups 2 and 4, but not in groups 6 and 8. It remained 
significantly lower after 1 week than under control condi- 
tions in groups 4, 6 and 8, but not in group 2. 
The pattern of the changes in motion of the 50% most 
abnormally contracting chords was completely identical to 
that of the total left anterior descending coronary artery 
territory except that after 24 h, the value in group 1 was 
Figure 3. Left ventricular regional wall motion (RWM) 
in the whole left anterior descending coronary artery 
territory measured with the centerline method (regional 
wall movement; iiiZi; expressed in standard deviations). 
Abbreviations and format as in Figure 2. 
rt -PA 
B’B 
rl-PA t3B OCCL 
2 
rt-PA 
e’B 
rr-PA 8B O(C1 
higher (but not significantly) than in the other groups (data 
not shown). 
Figure 4 shows that the whole pattern of changes for the 
number of contiguous chords with standardized chord mo- 
tion < -2 standard deviations observed in the groups studied 
after 24 h or 1 week was similar to the changes described for 
the mean standardized motion of 55 chords except that after 
24 h, the number of chords with a value of c-2 standard 
deviations was not only lower in group 1 than in groups 3 and 
7 but also than in group 5; in group 7, the increase in number 
of chords with standardized motion c-2 standard devia- 
tions was significant. 
Figure 5 shows the changes in total negative area. For 
the groups studied after 1 week, the pattern of changes was 
similar to those of mean standardized chord motion. For 
groups 1, 3, 5 and 7 evaluated after 24 h, it can be seen that 
the trend of the changes was similar to those of mean 
standardized chord motion except that the total negative 
area was not only less negative in group 1 than in groups 3 
and 7, but also in group 5, and that in group 7, the further 
decrease in total negative area was significant. 
I ZL HOURS, ,- I WCER -, 
rt-PA Bfj OCCL 
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Figure 4. Circumferential extent of severe hypo- 
kinesia measured by the number of contiguous 
chords with severe hvuokinesia (standardized 
motion c-2 standard -deviationsi (centerline 
method). Abbreviations and format as in Figure 
2. 
2 c 6 0 
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In summary, regional wall motion at 24 h improved in the 
combined treatment group (groups 1 and 2) compared with 
that in the reperfusion treatment group (groups 3 and 4) and 
the beta-blockade treatment group (groups 5 and 6). 
Discussion 
Limitations of the present study. The number of experi- 
mental animals in each treatment subgroup was only six for 
various reasons and, as a consequence, the statistical power 
of the study is rather limited. Although a major attempt was 
made to have a similar mean area at risk in each subgroup 
and no statistical differences were present among these 
groups, there were, nevertheless, differences that probably 
influenced some observations. Not only the area at risk, but 
also the extent of collateral flow during coronary occlusion 
influences infarct size. Collateral flow was not measured; it 
could have been different among the various subgroups and 
in this way have influenced the results. Metoprolol was 
administered very early after coronary occlusion in a single 
intravenous dose and was followed by early thrombolysis. 
These details of the experimental protocol might limit their 
applicability to the human situation. 
Effects of early beta-blockade alone. Previous studies 
(3-5,7,18) suggested that beta-adrenergic blocking agents 
limited infarct size, but more recent work (19,20) using risk 
zone analysis could not confirm these observations. In one 
recent study (21) showing a beneficial effect, the infarct size 
as a percent of perfusion area was 90%, which is definitely 
higher than in similar studies and in the present work. 
In our present study 24 h after coronary occlusion, infarct 
size related to perfusion area and left ventricular area was 
identical in control animals and those receiving metoprolol; 
in both these groups, the area at risk was very similar. The 
present data indicate that infarct size 24 h after acute 
occlusion of the left anterior descending coronary artery is 
not influenced by the early intravenous administration of 
metoprolol. From our findings, it is difficult to judge the 
I ZL MOWS -, ,- 1 WftK - 
Figure 5. Total negative area (centerline method) ex- 
pressed in standard deviations (sum of all negative 
chord motion values in the left anterior descending 
artery territory). Abbreviations and format as in Figure 
? 
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influence of early intravenous administration of metoprolol 
on infarct size after 1 week because of the limited number of 
observations and because the area at risk in the control 
group was higher than that in the beta-adrenergic blocker 
group. 
In animals receiving intravenous metoprolol, global and 
regional left ventricular function did not recuperate 24 h after 
coronary occlusion when compared to the immediate post- 
occlusion period. Instead, there was a tendency to a further 
decline of all studied variables, which, however, was not 
significant. The changes in global and regional left ventricu- 
lar function after 24 h were very similar in the control and 
beta-blocker groups, except that for some variables (left 
ventricular ejection fraction, number of chords with stan- 
dardized motion <-2 standard deviations, total negative 
area), the further deterioration was significant in control 
animals. It is not clear if this difference is dependent on 
metoprolol administration. One week after occlusion, global 
and regional left ventricular function were very similar in the 
control and metoprolol groups even though the area at risk in 
the latter group was smaller. The degree of recuperation of 
left ventricular function when compared with the immediate 
postocclusion period, was also nearly identical. Our data 
suggest that early intravenous administration of metoprolol 
after occlusion of the left anterior descending coronary 
artery in the anesthetized dog does not influence infarct size 
or global and regional left ventricular function to any signif- 
icant extent 24 h and 1 week after occlusion. 
Effects of thrombolysis alone. Timely coronary reperfu- 
sion has favorable effects on infarct size and left ventricular 
function in experimental myocardial infarction (6,7,8,9,22, 
23,24). In our control animals, 70 to 75% of the area at risk 
was infarcted at 24 h and at 1 week after coronary occlusion, 
which is comparable with that in other studies (19,25,26). 
Thromboiysis 1 h after coronary occlusion reduced the 
necrotic zone to 35 to 45% of the perfusion area of the left 
anterior descending coronary artery. This difference was 
significant in the group studied after 1 week, but not in the 
group evaluated after 24 h. Differences in collateral flow and 
the small number of animals in each subgroup very likely 
explain the lack of a significant reduction of infarct size after 
24 h. 
Global and regional left ventricular function 24 h after 
occlusion were very similar in the group that underwent 
thrombolysis and in the control group. In both groups, there 
was a tendency for further deterioration of left ventricular 
function; however, this was significant for some variables of 
regional left ventricular function only in the control group. 
Maroko et al. (6) reported an improvement in paradoxic 
motion in the infarct area after 1 h of reperfusion after a 3 h 
occlusion period; our present data, as do several other 
studies (7,8,9), show no recuperation, but rather a tendency 
to further deterioration of left ventricular function 24 h after 
coronary occlusion, even when followed by timely success- 
ful thrombolysis, as a result of myocardial “stunning” (27). 
One week after coronary occlusion, global and regional left 
ventricular function in the thrombolysis group had signifi- 
cantly improved when compared with the immediate postoc- 
elusion period, whereas in the control group, this improve- 
ment remained unsignificant. Global but not regional left 
ventricular function approached control values. Our results 
on recuperation of left ventricular function 1 week after 
occlusion are in agreement with previous studies (7-9) and 
with our previously published data (10). 
Effects of combined early beta-blockade and thrombolysis. 
Recent studies (10,28-30) suggest that early beta-adrenergic 
blockade combined with successful thrombolysis further 
reduces infarct size when compared with thrombolysis 
alone. In the present study, the area at risk in the beta- 
blockade plus thrombolysis group and the thrombolysis 
group evaluated at 24 h and 1 week were practically similar. 
Although the differences were not significant, infarct size in 
the combined treatment groups was nearly 50% lower than in 
the thrombolysis only group. The present data are, there- 
fore, in agreement with previous studies (28-30) and confirm 
our other recent data (10). It should be noted that in some of 
these reports (29,30), the beta-adrenergic blocking agent was 
administered intravenously during several hours to 1 day, 
which was different from the present study. 
The present study shows that the combinution of betu- 
blockade and thrombolysis had (I definite effect on global 
and regional left ventriculur function. In the three other 
treatment groups, all variables of left ventricular function 
tended to further deteriorate after 24 h when compared with 
the immediate postocclusion period. In contrast, in the 
combined treatment group, a moderate improvement was 
observed. As a consequence, a significant difference was 
found among left ventricular ejection fraction, number of 
chords with motion c-2 standard deviations and total 
negative area of wall motion in the combined treatment and 
other three groups; for mean standardized chord motion of 
55 chords, the difference between the thrombolysis and 
control groups was also significant. In our previous study 
(IO), the differences among the metoprolol-rt-PA group and 
the other groups were less marked both for global and 
regional left ventricular function. This is very likely related 
to the use of a more refined method for evaluating regional 
motion abnormalities (15) and to a better equalization of the 
area at risk in the different subgroups. No significant differ- 
ences in global and regional left ventricular function were 
found among the combined treatment group and the three 
other groups I week after occlusion. Nevertheless, some 
observations point to a persisting improvement in left ven- 
tricular regional function; regional wall motion values in the 
region of the left anterior descending coronary artery were 
no longer significantly different from control values. whereas 
in the other three groups, a significant difference persisted. 
In our previous study (lo), we also observed an earlier 
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recovery of left ventricular function, but no differences were 
observed after 1 week. However, in that study, regional left 
ventricular function was evaluated by a radial method and 
not by the centerline method. 
The present data do not permit us to speculate on the 
reasons why in this model of acute myocardial infarction 
beta-blocker therapy alone did not influence infarct size and 
left ventricular function, but nevertheless enhanced the 
effects of early thrombolysis. 
Conclusions. The present data confirm that intravenous 
administration of a single dose of metoprolol early after 
occlusion of the left anterior descending coronary artery in 
the dog does not influence infarct size or global and regional 
left ventricular function when evaluated after 24 h and 1 
week. The findings are also in agreement with previous 
studies that found that timely coronary reperfusion reduces 
infarct size. Thrombolysis did not improve global and re- 
gional left ventricular function after 24 h, but after 1 week 
definite favorable effects were observed. 
The present study strongly suggests that in animals re- 
ceiving the combination of early beta-blockade and timely 
thrombolysis, the infarct size after acute left anterior de- 
scending coronary artery occlusion is reduced when evalu- 
ated after 24 h and 1 week. An early recovery of global and 
regional left ventricular function was observed 24 h after 
occlusion; 1 week after occlusion, a better recuperation of 
regional left ventricular function persisted. These observa- 
tions suggest that although early intravenous beta-adrenergic 
blockade alone has no definite effects on infarct size and left 
ventricular function, its combination with early thrombolysis 
further enhances the beneficial effects of thrombolysis alone. 
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